SleepX
SleepX, licence 80053199: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Other names
- 88herbs
- Licence holder
- BB&G Health Corp
- NPN or DIN-HM
- 80053199
- Status
- Active licence
- Licence date
- 18 August 2014
- Revision date
- 3 October 2014
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| 3-Pyridinecarboxamide Source : Niacinamide | 4.5 mg | Not calculated |
| N-éthyl-L-glutamine Source : L-Théanine | 125.0 mg | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Mélatonine | 1.5 mg | Not calculated |
| N-acétyl-5-méthoxytryptamine Source : Animaux autre que l'humain non susceptibles à l' EST - Corps pinéal | 1.5 mg | Not calculated |
| L-tryptophane Source : Tryptophane | 100.0 mg | Not calculated |
| Passiflora incarnata Source : Plante Extract : Matériel brut sec Extraction ratio : 4.0:1 Dry plant equivalent : 1000 mg Potency : 20.0 % Bioflavonoids | 250.0 mg | Not calculated |
Non-medicinal ingredients
Cellulose microcristalline, Hypromellose, Dioxyde de silicium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | minimum: 1.0 Capsule ; maximum: 2.0 Capsule | 1.0 Jour(s) |
Uses authorised in Canada
A factor in the maintenance of good health. Source of an essential amino acid for the maintenance of good health. Helps to increase the total sleep time (aspect of sleep quality) in people suffering from sleep restriction or altered sleep schedule. Helps to prevent and/or reduce the effects of jet lag (e.g. daytime fatigue, sleep disturbance) for people travelling by plane easterly across two or more time zones. Helps to reduce the time it takes to fall asleep (sleep onset latency aspect of sleep quality) in people with delayed sleep phase disorder. Helps to re-set the body's sleep-wake cycle (aspect of the circadian rhythm). Helps the body to metabolize carbohydrates, proteins, and fats. Helps in the development and maintenance of bones and teeth. Helps in tissue formation. Helps to maintain proper muscle function.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consumption with alcohol, other drugs or natural health products with sedative properties is not recommended. Consult a health care practitioner prior to use if you have benign prostate hypertrophy and/or prostate cancer. Consult a health care practitioner prior to use if you are taking carbidopa or drugs/supplements with serotonergic activity. These may include, but are not limited to, L-tryptophan, S-adenosylmethionine (SAMe), St. John's wort, antidepressants, pain killers, over the counter cough and cold medication containing dextromethorphan, anti-nausea medication and anti-migraine medication. Discontinue use and consult a health care practitioner if you show signs of weakness, oral ulcers, or abdominal pain accompanied by severe muscle pain or if you experience skin changes. If symptoms persist for more than 4 weeks (chronic insomnia), consult your health care practitioner. Consult a health care practitioner prior to use if you have asthma, cardiovascular disease, kidney disease, depression, diabetes or hypoglycaemia, hormonal disorder, immune system disease, liver disease, migraines, and/or seizure disorders. Consult a health care practitioner prior to use if you are taking anticoagulant, anticonvulsant, blood pressure, immunosuppressive, sedative, hypnotic or psychotropic medications and/or steroids. Some people may experience drowsiness. Exercise caution if operating heavy machinery, driving a motor vehicle or involved in activities requiring mental alertness.
- Contre-indications
Do not use if you have scleroderma. If you are pregnant or breastfeeding, do not use this product.
Source
Official Health Canada record, licence 80053199
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2014. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.